Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome?positive (Ph+) acute lymphoblastic leukemia(ALL).
This report aims to provide a comprehensive presentation of the global market for Ponatinib Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ponatinib Drugs. This report contains market size and forecasts of Ponatinib Drugs in global, including the following market information:
Global Ponatinib Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Ponatinib Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Ponatinib Drugs companies in 2022 (%)
The global Ponatinib Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
45mg Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ponatinib Drugs include ARIAD Pharmaceuticals. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ponatinib Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ponatinib Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Ponatinib Drugs Market Segment Percentages, by Type, 2022 (%)
45mg
15mg
Global Ponatinib Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Ponatinib Drugs Market Segment Percentages, by Application, 2022 (%)
CML
ALL
Global Ponatinib Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Ponatinib Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ponatinib Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ponatinib Drugs revenues share in global market, 2022 (%)
Key companies Ponatinib Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Ponatinib Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ARIAD Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ponatinib Drugs, market overview.
Chapter 2: Global Ponatinib Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Ponatinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ponatinib Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ponatinib Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ponatinib Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ponatinib Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ponatinib Drugs Overall Market Size
2.1 Global Ponatinib Drugs Market Size: 2022 VS 2030
2.2 Global Ponatinib Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Ponatinib Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Ponatinib Drugs Players in Global Market
3.2 Top Global Ponatinib Drugs Companies Ranked by Revenue
3.3 Global Ponatinib Drugs Revenue by Companies
3.4 Global Ponatinib Drugs Sales by Companies
3.5 Global Ponatinib Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ponatinib Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ponatinib Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ponatinib Drugs Players in Global Market
3.8.1 List of Global Tier 1 Ponatinib Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Ponatinib Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ponatinib Drugs Market Size Markets, 2022 & 2030
4.1.2 45mg
4.1.3 15mg
4.2 By Type - Global Ponatinib Drugs Revenue & Forecasts
4.2.1 By Type - Global Ponatinib Drugs Revenue, 2018-2023
4.2.2 By Type - Global Ponatinib Drugs Revenue, 2024-2030
4.2.3 By Type - Global Ponatinib Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Ponatinib Drugs Sales & Forecasts
4.3.1 By Type - Global Ponatinib Drugs Sales, 2018-2023
4.3.2 By Type - Global Ponatinib Drugs Sales, 2024-2030
4.3.3 By Type - Global Ponatinib Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Ponatinib Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ponatinib Drugs Market Size, 2022 & 2030
5.1.2 CML
5.1.3 ALL
5.2 By Application - Global Ponatinib Drugs Revenue & Forecasts
5.2.1 By Application - Global Ponatinib Drugs Revenue, 2018-2023
5.2.2 By Application - Global Ponatinib Drugs Revenue, 2024-2030
5.2.3 By Application - Global Ponatinib Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Ponatinib Drugs Sales & Forecasts
5.3.1 By Application - Global Ponatinib Drugs Sales, 2018-2023
5.3.2 By Application - Global Ponatinib Drugs Sales, 2024-2030
5.3.3 By Application - Global Ponatinib Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Ponatinib Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Ponatinib Drugs Market Size, 2022 & 2030
6.2 By Region - Global Ponatinib Drugs Revenue & Forecasts
6.2.1 By Region - Global Ponatinib Drugs Revenue, 2018-2023
6.2.2 By Region - Global Ponatinib Drugs Revenue, 2024-2030
6.2.3 By Region - Global Ponatinib Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Ponatinib Drugs Sales & Forecasts
6.3.1 By Region - Global Ponatinib Drugs Sales, 2018-2023
6.3.2 By Region - Global Ponatinib Drugs Sales, 2024-2030
6.3.3 By Region - Global Ponatinib Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Ponatinib Drugs Revenue, 2018-2030
6.4.2 By Country - North America Ponatinib Drugs Sales, 2018-2030
6.4.3 US Ponatinib Drugs Market Size, 2018-2030
6.4.4 Canada Ponatinib Drugs Market Size, 2018-2030
6.4.5 Mexico Ponatinib Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Ponatinib Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Ponatinib Drugs Sales, 2018-2030
6.5.3 Germany Ponatinib Drugs Market Size, 2018-2030
6.5.4 France Ponatinib Drugs Market Size, 2018-2030
6.5.5 U.K. Ponatinib Drugs Market Size, 2018-2030
6.5.6 Italy Ponatinib Drugs Market Size, 2018-2030
6.5.7 Russia Ponatinib Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Ponatinib Drugs Market Size, 2018-2030
6.5.9 Benelux Ponatinib Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Ponatinib Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Ponatinib Drugs Sales, 2018-2030
6.6.3 China Ponatinib Drugs Market Size, 2018-2030
6.6.4 Japan Ponatinib Drugs Market Size, 2018-2030
6.6.5 South Korea Ponatinib Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Ponatinib Drugs Market Size, 2018-2030
6.6.7 India Ponatinib Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Ponatinib Drugs Revenue, 2018-2030
6.7.2 By Country - South America Ponatinib Drugs Sales, 2018-2030
6.7.3 Brazil Ponatinib Drugs Market Size, 2018-2030
6.7.4 Argentina Ponatinib Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ponatinib Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Ponatinib Drugs Sales, 2018-2030
6.8.3 Turkey Ponatinib Drugs Market Size, 2018-2030
6.8.4 Israel Ponatinib Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Ponatinib Drugs Market Size, 2018-2030
6.8.6 UAE Ponatinib Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 ARIAD Pharmaceuticals
7.1.1 ARIAD Pharmaceuticals Company Summary
7.1.2 ARIAD Pharmaceuticals Business Overview
7.1.3 ARIAD Pharmaceuticals Ponatinib Drugs Major Product Offerings
7.1.4 ARIAD Pharmaceuticals Ponatinib Drugs Sales and Revenue in Global (2018-2023)
7.1.5 ARIAD Pharmaceuticals Key News & Latest Developments
8 Global Ponatinib Drugs Production Capacity, Analysis
8.1 Global Ponatinib Drugs Production Capacity, 2018-2030
8.2 Ponatinib Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Ponatinib Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ponatinib Drugs Supply Chain Analysis
10.1 Ponatinib Drugs Industry Value Chain
10.2 Ponatinib Drugs Upstream Market
10.3 Ponatinib Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ponatinib Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Ponatinib Drugs in Global Market
Table 2. Top Ponatinib Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ponatinib Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ponatinib Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Ponatinib Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Ponatinib Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ponatinib Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Ponatinib Drugs Product Type
Table 9. List of Global Tier 1 Ponatinib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ponatinib Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ponatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Ponatinib Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ponatinib Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Ponatinib Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Ponatinib Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Ponatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Ponatinib Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ponatinib Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Ponatinib Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Ponatinib Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Ponatinib Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Ponatinib Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ponatinib Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Ponatinib Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Ponatinib Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Ponatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ponatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Ponatinib Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Ponatinib Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Ponatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ponatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Ponatinib Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Ponatinib Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Ponatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ponatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Ponatinib Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Ponatinib Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Ponatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ponatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Ponatinib Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Ponatinib Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Ponatinib Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ponatinib Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Ponatinib Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Ponatinib Drugs Sales, (K Units), 2024-2030
Table 46. ARIAD Pharmaceuticals Company Summary
Table 47. ARIAD Pharmaceuticals Ponatinib Drugs Product Offerings
Table 48. ARIAD Pharmaceuticals Ponatinib Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. ARIAD Pharmaceuticals Key News & Latest Developments
Table 50. Ponatinib Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Ponatinib Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Ponatinib Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Ponatinib Drugs Production by Region, 2024-2030 (K Units)
Table 54. Ponatinib Drugs Market Opportunities & Trends in Global Market
Table 55. Ponatinib Drugs Market Drivers in Global Market
Table 56. Ponatinib Drugs Market Restraints in Global Market
Table 57. Ponatinib Drugs Raw Materials
Table 58. Ponatinib Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Ponatinib Drugs Downstream
Table 60. Ponatinib Drugs Downstream Clients in Global Market
Table 61. Ponatinib Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ponatinib Drugs Segment by Type in 2022
Figure 2. Ponatinib Drugs Segment by Application in 2022
Figure 3. Global Ponatinib Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ponatinib Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ponatinib Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Ponatinib Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Ponatinib Drugs Revenue in 2022
Figure 9. By Type - Global Ponatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Ponatinib Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Ponatinib Drugs Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Ponatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Ponatinib Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Ponatinib Drugs Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Ponatinib Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Ponatinib Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Ponatinib Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Ponatinib Drugs Sales Market Share, 2018-2030
Figure 23. US Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Ponatinib Drugs Sales Market Share, 2018-2030
Figure 28. Germany Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Ponatinib Drugs Sales Market Share, 2018-2030
Figure 37. China Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Ponatinib Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Ponatinib Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Ponatinib Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Ponatinib Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Ponatinib Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Ponatinib Drugs by Region, 2022 VS 2030
Figure 54. Ponatinib Drugs Industry Value Chain
Figure 55. Marketing Channels
